We explore some of the key themes o the agenda for The MedTech Forum from MDR to Digital Twins
Read More
What does it take to bring a cannabinoid pharmaceutical to market? On Tuesday 23rd May Clare Foy (Global Market Access Director – Mtech Access) was joined by Michael Sassano (CEO...
Read More
What are surrogate endpoints and how can they support the accelerated approval of new medicines? Where and how are surrogate endpoints being used? In which disease areas and markets can...
Read More
Helen Lilley tells us about her experiences and activities as a medical writer at Mtech Access, supporting projects from local communication materials to global value dossiers to HTA submissions.
Heather Wellam (Senior Consultant – Market Access) explains the cost-effectiveness analysis process in Japan, answering FAQs and exploring challenges and opportunities.
As our developers experiment with integrating AI into our tools, we demonstrate the potential (and current limitations) of this technology with ChatGPT
Visit our virtual booth We are delighted to announce that we will be exhibiting at The MedTech Forum on 30th May – 1st June in Dublin. The event is MedTech...
Read More
Katie Rose (Market Access Consultant) tells is about her experiences and activities in her first few weeks with us.
Working with a dedicated market access and health economics and outcomes research (HEOR) consultancy offers significant added value to Pharma and Medical Device companies and can give you the confidence...
Read More
We sit down with Heather Wellam (Senior Consultant – Market Access) to learn more about her work managing global market access, pricing and strategy projects. Heather shares how her work involves helping Pharma and Medtech companies to navigate complex and evolving healthcare systems to achieve market access.
